Navigation Links
Iomai to Announce Results From Phase 1 Influenza Trial and Host,Webcast Tomorrow

TCI taps into the unique benefits of a major group of antigen-presenting cells found in the outer layers of the skin (Langerhans cells) to generate an enhanced immune response. Iomai is leveraging TCI to enhance the efficacy of existing vaccines, develop new vaccines that are viable only through transcutaneous administration and expand the global vaccine market. Iomai currently has four product candidates in development: three targeting influenza and pandemic flu and one to prevent E. coli-related travelers' diarrhea. For more information on Iomai, please visit http://www.iomai.com.

CONTACT: Russell P. Wilson, Senior Vice President, Chief Financial Officerand General Counsel, of Iomai Corporation, +1-301-556-4478,; or Brian Reid of WeissComm Partners, Inc.,+1-703-402-3626, , for Iomai Corporation investors@iomai.com breid@weisscommpartners.com

Web site: http://www.iomai.com/

Ticker Symbol: (NASDAQ-NMS:IOMI)

Terms and conditions of use apply
Copyright © 2007 PR Newswire Association LLC. All rights reserved.
A United Business Media Company


'"/>




Page: 1 2

Related medicine technology :

1. Iomai Dose-Ranging Trial Demonstrates Needle-Free Patch Vaccine for Travelers Diarrhea Stimulates Immune Response Even at Low Doses
2. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
3. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
4. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
6. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
7. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
8. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
9. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
10. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
11. Protox Announces Positive Clinical Data from Prostate Cancer Study
Post Your Comments:
(Date:5/23/2013)... --  BioLife Solutions , Inc. (OTC:BLFS), a leading developer, ... storage and cryopreservation freeze media for ... , today announced its participation at the Terrapinn ... this week in London . ... J. Mathew, BioLife,s Senior Vice President and Chief Technology ...
(Date:5/23/2013)... Switzerland and DRESDEN, ... -- Cenix BioScience, a leading preclinical ... RNAi-, miRNA- and high content-driven pharmacology, and Debiopharm ... companies with a focus on the development of ... oncology and companion diagnostics, today announced that they ...
(Date:5/22/2013)... Calif. , May 22, 2013 Advanced ... a medical device that will help alleviate the high ... targeted apheresis cartridge is expected to be the first ... cause of maternal and fetal death. Every ... the United States . It is characterized ...
Breaking Medicine Technology:BioLife Solutions Announces Presentation at 8th World Stem Cells & Regenerative Medicine Congress 2BioLife Solutions Announces Presentation at 8th World Stem Cells & Regenerative Medicine Congress 3Cenix BioScience and Debiopharm Group Collaborate to Identify Predictive Biomarkers 2Cenix BioScience and Debiopharm Group Collaborate to Identify Predictive Biomarkers 3Cenix BioScience and Debiopharm Group Collaborate to Identify Predictive Biomarkers 4Advanced Prenatal Therapeutics - Using Targeted Apheresis to Treat Preeclampsia 2
... and AMSTERDAM, December 13 ,Dr. Michael Knauer from ... substantial group of traditionally miscategorized low risk HER2+,patients. ... was used to differentiate between patients at high ... HER2+ patients are commonly identified ...
... December 12 ,Agendia, a world leader in molecular ... to neoadjuvant chemotherapy in,breast cancer. , ... Veer, from the Netherlands Cancer Institute, presented,the data ... (SABCS) during the,session Molecular profiling for guiding therapeutic ...
Cached Medicine Technology:Agendia's Breast Cancer Test MammaPrint(R) Identifies New Subset of Low Risk HER2+ Patients 2Agendia's Breast Cancer Test MammaPrint(R) Identifies New Subset of Low Risk HER2+ Patients 3Agendia's MammaPrint(R) Predicts Response to Neoadjuvant Chemotherapy in Breast Cancer 2
(Date:5/23/2013)... 2013 Sharon Kleyne and Bio Logic ... product to supplement natural tear film water due to ... Nature’s Tears® EyeMist®, according to Kleyne, is the “first ... fresh water mist to the air around the eyes, ... describes herself as “educator, inventor, radio commentator and water ...
(Date:5/23/2013)... May 23, 2013 With crowded gyms, ... popular. But according to Mike Whitfield, a bodyweight expert ... equipment like the medicine ball can add a whole ... runs BodyweightTorch.com, a website in which anyone can download ... no equipment. Recently, he shared a video with his ...
(Date:5/23/2013)... D.C. (PRWEB) May 23, 2013 Studies show ... more times per week are less likely to be overweight, ... alcohol, perform better academically, and have better relationships with their ... is in danger, according to family dinner expert and advocate ... dinners have declined by 33 percent. When families do eat ...
(Date:5/23/2013)... May 23, 2013 Dr. Garber's ... condition specific remedies are now available at Whole Foods ... CA 92677. The line of natural biotherapy formulas continues ... Chain. , Represented by Brandstorm HBC (Los Angeles, CA), ... Markets throughout California, Nevada and Arizona, as well as ...
(Date:5/23/2013)... 23, 2013 Brad Schmett, Broker Associate ... the already sizzling Palm Springs area real estate ... the immense popularity of the Annual Memorial Day Flower ... May 27, 2013. , Culminating the festive three-day weekend, ... and events along with flight exhibitions. However, the highlight ...
Breaking Medicine News(10 mins):Health News:Water Entrepreneur Announces First Ever Personal Dry Eye Humidifier 2Health News:Unique Ab Exercise, the Medicine Ball Chop, Released from BodyweightTorch.com 2Health News:Family Dinner Expert and Cookbook Author Announces “Family Dinner Challenge” 2Health News:Dr. Garber's Natural Solutions Now Available at Whole Foods Market, Laguna Niguel, CA 2Health News:Annual Memorial Day Flower Drop Honors Veterans in Palm Springs California by Brad Schmett 2
... , ... firm Jackson & Coker ranked #3 on SIA’s 2009 list of “Ten Best Staffing ... , ... December 11, 2009 -- Each year, Staffing Industry Analysts, a premier research and analysts ...
... The Phoenix Business Journal and BestCompaniesAZ, co-founders ... SCAN Health Plan Arizona has been named to the 2009 ... employees, who provided extensive insight into employee life. , SCAN ... culture and work environment that fosters personal and professional growth ...
... estrogen-positive tumors, study found , THURSDAY, Dec. 10 ... tamoxifen can boost survival in postmenopausal women with ... as estrogen receptor-positive, and it,s best given before ... study. , "Chemotherapy with Adriamycin adds to your ...
... , U.S. Rep. Gerry Connolly (D-Va.) Also to ... 10 The Federal Employees Health Benefits Plan (FEHBP) open enrollment period ... (AFGE) "Inside Government" radio program. The show will air on Friday, ... www.federalnewsradio.com and 1500 AM in the ...
... , DETROIT, Dec. 10 African-American political leaders, ... Monday, December 14th to create and implement a ... African-American Community. , "Detroit is leading the nation ... the Rev. Horace Sheffield III, National Board Member and ...
... to prevent recurrence, researchers find , THURSDAY, Dec. 10 ... millions of women to fight osteoporosis also cut the ... a dual role in keeping women healthy. , ... of breast cancer therapy. Our feeling is that bisphosphonates ...
Cached Medicine News:Health News:Jackson & Coker Ranks #3 among “Ten Best Staffing Firms to Work For” 2Health News:Jackson & Coker Ranks #3 among “Ten Best Staffing Firms to Work For” 3Health News:Jackson & Coker Ranks #3 among “Ten Best Staffing Firms to Work For” 4Health News:SCAN Health Plan Arizona Named one of Area's Best Places to Work by the Phoenix Business Journal and BestCompaniesAZ, LLC 2Health News:Adding Chemo to Tamoxifen Helps Some Breast Cancer Patients 2Health News:Adding Chemo to Tamoxifen Helps Some Breast Cancer Patients 3Health News:FEHBP Open Enrollment Period to be Discussed on Special Rebroadcast of 'Inside Government' 2Health News:Black Community Unites Against HIV/AIDS Epidemic 2Health News:Bone Drugs May Beat Back Breast Cancer 2
Bivona® stylets are manufactured of malleable stainless steel wire. The length can be adjusted by sliding the attached silicone stopper. The Blue Line® tracheal tube introducer (bougie) is de...
All endotracheal accessories are designed to ensure your technique. The Blue Line® intubation stylets feature a satin-smooth coating and are available in three sizes....
... of flexible lighting products. The first is ... different sizes 5", 10", and 15" (refers ... light). These lights are for use in ... ,The second group of flexible lights is ...
... two groups of flexible lighting products. The ... in three different sizes 5", 10", and ... of the light). These lights are for ... needed., ,The second group of flexible ...
Medicine Products: